United Therapeutics Corporation (NASDAQ:UTHR) Investor Investigation over Potential Wrongdoing
An investigation on behalf of investors in shares of United Therapeutics Corporation was announced over potential breaches of fiduciary duties by certain officers and directors at United Therapeutics.
View full press release